These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
298 related items for PubMed ID: 33557763
41. Predictors for functionally significant in-stent restenosis: an integrated analysis using coronary angiography, IVUS, and myocardial perfusion imaging. Kang SJ, Cho YR, Park GM, Ahn JM, Han SB, Lee JY, Kim WJ, Park DW, Lee SW, Kim YH, Lee CW, Park SW, Mintz GS, Park SJ. JACC Cardiovasc Imaging; 2013 Nov; 6(11):1183-90. PubMed ID: 24229771 [Abstract] [Full Text] [Related]
42. Circulating miR-6821-5p levels and coronary calcification in asymptomatic familial hypercholesterolemia patients. Escate R, Padró T, Pérez de Isla L, Fuentes F, Alonso R, Mata P, Badimon L. Atherosclerosis; 2024 May; 392():117502. PubMed ID: 38513437 [Abstract] [Full Text] [Related]
43. Circulating microRNAs as potential biomarkers for coronary plaque rupture. Li S, Lee C, Song J, Lu C, Liu J, Cui Y, Liang H, Cao C, Zhang F, Chen H. Oncotarget; 2017 Jul 18; 8(29):48145-48156. PubMed ID: 28624816 [Abstract] [Full Text] [Related]
44. Intravascular ultrasound assessment of optimal stent area to prevent in-stent restenosis after zotarolimus-, everolimus-, and sirolimus-eluting stent implantation. Song HG, Kang SJ, Ahn JM, Kim WJ, Lee JY, Park DW, Lee SW, Kim YH, Lee CW, Park SW, Park SJ. Catheter Cardiovasc Interv; 2014 May 01; 83(6):873-8. PubMed ID: 22815193 [Abstract] [Full Text] [Related]
45. MiR-223-3p and miR-122-5p as circulating biomarkers for plaque instability. Singh S, de Ronde MWJ, Kok MGM, Beijk MA, De Winter RJ, van der Wal AC, Sondermeijer BM, Meijers JCM, Creemers EE, Pinto-Sietsma SJ. Open Heart; 2020 Jun 01; 7(1):. PubMed ID: 32487772 [Abstract] [Full Text] [Related]
46. Plasma levels of miR-143 and miR-145 are associated with coronary in-stent restenosis within 1 year of follow-up after drug-eluting stent implantation. Yuan Y, Liu X, Hao S, He Q, Shen Z. Ann Transl Med; 2020 Jun 01; 8(12):756. PubMed ID: 32647681 [Abstract] [Full Text] [Related]
47. High red blood cell distribution width is closely associated with in-stent restenosis in patients with unstable angina pectoris. Geng N, Su G, Wang S, Zou D, Pang W, Sun Y. BMC Cardiovasc Disord; 2019 Jul 24; 19(1):175. PubMed ID: 31340761 [Abstract] [Full Text] [Related]
48. Circulating Extracellular miRNA Analysis in Patients with Stable CAD and Acute Coronary Syndromes. Zhelankin AV, Stonogina DA, Vasiliev SV, Babalyan KA, Sharova EI, Doludin YV, Shchekochikhin DY, Generozov EV, Akselrod AS. Biomolecules; 2021 Jun 29; 11(7):. PubMed ID: 34209965 [Abstract] [Full Text] [Related]
49. Coronary in-stent restenosis: predisposing clinical and stent-related factors, diagnostic performance and analyses of inaccuracies in 320-row computed tomography angiography. Wan YL, Tsay PK, Chen CC, Juan YH, Huang YC, Chan WH, Wen MS, Hsieh IC. Int J Cardiovasc Imaging; 2016 Jun 29; 32 Suppl 1():105-15. PubMed ID: 27106698 [Abstract] [Full Text] [Related]
50. Usefulness of the platelet-to-lymphocyte ratio in predicting bare-metal stent restenosis. Yılmaz S, Sen F, Ünal S, Yayla C, Özeke Ö, Aras D, Topaloglu S, Aydogdu S. Scand Cardiovasc J; 2015 Feb 29; 49(1):39-44. PubMed ID: 25414124 [Abstract] [Full Text] [Related]
51. Circulating miR-208b: A Potentially Sensitive and Reliable Biomarker for the Diagnosis and Prognosis of Acute Myocardial Infarction. Liu X, Yuan L, Chen F, Zhang L, Chen X, Yang C, Han Z. Clin Lab; 2017 Jan 01; 63(1):101-109. PubMed ID: 28164501 [Abstract] [Full Text] [Related]
52. Circulating miR-3197 and miR-2116-5p as novel biomarkers for diabetic retinopathy. Ji H, Yi Q, Chen L, Wong L, Liu Y, Xu G, Zhao J, Huang T, Li B, Yang Y, Li W, Han L, Duan S. Clin Chim Acta; 2020 Feb 01; 501():147-153. PubMed ID: 31678272 [Abstract] [Full Text] [Related]
53. Angiographic patterns of drug-eluting stent restenosis after treatment with drug-coated balloon versus balloon angioplasty: Late lumen loss subgroup analyses of the PEPCAD-DES study. Rittger H, Wöhrle J, Brachmann J, Hohenforst-Schmidt W, Schlundt C, Lonke S, von Cranach M, Markovic S, Achenbach S, Waliszewski M. Catheter Cardiovasc Interv; 2016 Oct 01; 88(4):529-534. PubMed ID: 26893095 [Abstract] [Full Text] [Related]
54. MiR-93-5p is a novel predictor of coronary in-stent restenosis. O'Sullivan JF, Neylon A, Fahy EF, Yang P, McGorrian C, Blake GJ. Heart Asia; 2019 Oct 01; 11(1):e011134. PubMed ID: 31031831 [Abstract] [Full Text] [Related]
55. Circulating miR-106b-5p serves as a diagnostic biomarker for asymptomatic carotid artery stenosis and predicts the occurrence of cerebral ischemic events. Zhang T, Chen Z, Yang X, Fu R, Wang J, Xu H. Vasc Med; 2020 Oct 01; 25(5):436-442. PubMed ID: 32558619 [Abstract] [Full Text] [Related]
56. The correlation of circulating pro-angiogenic miRNAs' expressions with disease risk, clinicopathological features, and survival profiles in gastric cancer. Peng W, Liu YN, Zhu SQ, Li WQ, Guo FC. Cancer Med; 2018 Aug 01; 7(8):3773-3791. PubMed ID: 30003708 [Abstract] [Full Text] [Related]
57. Elevated level of miR-17 along with decreased levels of TIMP-1 and IL-6 in plasma associated with the risk of in-stent restenosis. Jiang F, Zhang X, Lu YM, Li YG, Zhou X, Wang YS. Biosci Trends; 2019 Nov 13; 13(5):423-429. PubMed ID: 31666440 [Abstract] [Full Text] [Related]
58. Association between asymmetric dimethylarginine and in-stent restenosis tissue characteristics assessed by optical coherence tomography. Huang WC, Teng HI, Chen HY, Wu CJ, Tsai CT, Hsueh CH, Chen YY, Hau WK, Lu TM. Int J Cardiol; 2019 Aug 15; 289():131-137. PubMed ID: 31079970 [Abstract] [Full Text] [Related]
59. Circulating microRNAs as biomarkers for severe coronary artery disease. Zhang X, Cai H, Zhu M, Qian Y, Lin S, Li X. Medicine (Baltimore); 2020 Apr 15; 99(17):e19971. PubMed ID: 32332683 [Abstract] [Full Text] [Related]
60. Use of the neutrophil to lymphocyte ratio for prediction of in-stent restenosis in bifurcation lesions. Balli M, Taşolar H, Çetin M, Tekin K, Çağliyan ÇE, Türkmen S, Yilmaz M, Elbasan Z, Şahin DY, Çayli M. Eur Rev Med Pharmacol Sci; 2015 May 15; 19(10):1866-73. PubMed ID: 26044233 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]